Portions of this exhibit have been redacted because they are both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. Information that was omitted has been noted in this document with a placeholder identified by the...Option Agreement • March 18th, 2022 • Genocea Biosciences, Inc. • Biological products, (no disgnostic substances) • Delaware
This Collaboration & Option Agreement (“Agreement”) is dated December 28, 2021, (the “Effective Date”) and is between Janssen Biotech Inc., a company having a place of business at 800/850 Ridgeview Drive, Horsham PA 19044 (“Janssen”) and Genocea Biosciences, Inc., a company having a place of business at 100 Acorn Park Drive, Cambridge, MA 02140 (“Genocea”).
